D. Estévez

Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab

K. Leon, L. Sanchez, T. Crombet, 2020, Clinical & translational immunology.

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

K. Leon, M. Ramos-Suzarte, P. Lorenzo-Luaces, 2020, Gerontology.

Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer

E. Santiesteban, S. Acosta, C. Viada, 2014 .